Hiroyuki Fujikawa

Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer

Yoshinaga Okugawa, Yuji Toiyama, Akira Yamamoto et al. · Annals of Surgery · 2019 · 293 citations

Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer

Hiroki Imaoka, Yuji Toiyama, Hiroyuki Fujikawa et al. · Annals of Oncology · 2016 · 144 citations

Medicine, Colorectal Cancer, Pathology +9

Lymphocyte-to-C-reactive protein ratio and score are clinically feasible nutrition-inflammation markers of outcome in patients with gastric cancer

Yoshinaga Okugawa, Yuji Toiyama, Akira Yamamoto et al. · Clinical Nutrition · 2019 · 141 citations

Inflammation, Nutrition, Feasible Nutrition-inflammation Markers +11

Soluble PD-L1 Expression in Circulation as a Predictive Marker for Recurrence and Prognosis in Gastric Cancer: Direct Comparison of the Clinical Burden Between Tissue and Serum PD-L1 Expression

Tsunehiko Shigemori, Yuji Toiyama, Yoshinaga Okugawa et al. · Annals of Surgical Oncology · 2018 · 96 citations

Prognostic Biomarkers, Gastrointestinal Oncology, Soluble Pd-l1 Expression +8

Co‐expression of hepatocyte growth factor and c‐Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c‐Met signaling in gastric cancer

Yuji Toiyama, Hiromi Yasuda, Susumu Saigusa et al. · International Journal of Cancer · 2011 · 94 citations

Pathology, Cancer Biology, Tumor Biology +19